GlassScriptPhysician profile
Jacqueline A Cox
NPI 1538153564
$517.11
in general payments reported to CMS, 2019-2025
17 companies · $89.82 in 2025
The $89.82 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2021: $25.85 · 2022: $48.37 · 2023: $96.43 · 2024: $109 · 2025: $89.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $270 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.61 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $76.61 | 2019-2025 | Lunsumio |
| Astrazeneca Pharmaceuticals LP | $72.22 | 2024-2025 | Calquence, Imfinzi, Lynparza |
| E.R. Squibb & Sons, L.L.C. | $48.24 | 2022-2024 | Opdivo |
| Janssen Biotech, INC. | $47.16 | 2023-2025 | Erleada |
| Alexion Pharmaceuticals, INC. | $26.87 | 2024 | |
| Foundation Medicine, INC. | $26.54 | 2019 | |
| Amgen INC. | $26.30 | 2023 | Kyprolis |
| Abbvie INC. | $25.87 | 2023 | Venclexta |
| Merck Sharp & Dohme LLC | $25.70 | 2025 | Keytruda |
| Incyte Corporation | $22.61 | 2019 | |
| Genzyme Corporation | $21.89 | 2019 | |
| Exelixis INC. | $20.96 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $18.48 | 2022 | |
| Immunogen, INC. | $16.06 | 2023 | Elahere |
| Emd Serono, INC. | $15.75 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acrotech Biopharma INC. | $13.93 | 2021 | |
| Gilead Sciences, INC. | $11.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.